David Lazar
Interim Chief Executive Officer at Cyclacel Pharmaceuticals.
- Berkeley Heights, NJ
- Form D signer
- Cyclacel Pharmaceuticals
Raised on Cyclacel Pharmaceuticals filings
$1M
across 3 Form D filings
- Form D filings
- 3
- Teammates
- 3
- Last filing
- Mar 25, 2025
Company
Cell cycle drugs for drug-resistant cancers
- Investors
- 1
- Still open
- $25M
Cyclacel Pharmaceuticals filings
| Filed | Security | Sold of offered | Filing |
|---|---|---|---|
| Mar 25, 2025 | Equity | $1M/ $1M | Form D |
| Feb 14, 2025 | Equity | None sold/ no target | Form D |
| Feb 14, 2025 | Equity | None sold/ $25M | Form D |
